SCOPUS 정보 검색 플랫폼

Metabolism: Clinical and Experimental

Volumn 45, Issue SUPPL.1, 1996, Pages 63-64

Treatment options for acromegaly

(2) Sheppard, M C a,b Stewart, P M a

a UNIVERSITY OF BIRMINGHAM (United Kingdom)

b UNIVERSITY DEPARTMENT OF MEDICINE (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; BROMOCRIPTINE MESILATE; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C;

ACROMEGALY; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; INTRAMUSCULAR DRUG ADMINISTRATION; NEUROSURGERY; PRIORITY JOURNAL;

ACROMEGALY; GROWTH HORMONE; HUMANS; OCTREOTIDE; TREATMENT OUTCOME;

EID: 0029832211 PISSN: 00260495 EISSN: None Source Type: Journal
DOI: 10.1016/S0026-0495(96)90085-2 Document Type: Article

Times cited : (3)

References (10)

1
- 0025700486
- Acromegaly
- Melmed S: Acromegaly. N Engl J Med 322:966-977, 1990
- (1990) N Engl J Med , vol.322 , pp. 966-977
- Melmed, S.¹

2
- 0027300715
- An audit of outcome of treatment in acromegaly
- Bates AS, Van't Hoff W, Jones JM, et al: An audit of outcome of treatment in acromegaly. Q J Med 86:293-299, 1993
- (1993) Q J Med , vol.86 , pp. 293-299
- Bates, A.S.¹ Van't Hoff, W.² Jones, J.M.³

3
- 0027989713
- Determinants of clinical outcome and survival in acromegaly
- Rajasoorya C, Holdaway M, Wrightson P, et al: Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol 41:95-102, 1994
- (1994) Clin Endocrinol , vol.41 , pp. 95-102
- Rajasoorya, C.¹ Holdaway, M.² Wrightson, P.³

4
- 0028221215
- Persistence of rapid growth hormone pulsatility after successful removal of GH-producing pituitary tumours
- Ho PJ, Jaffe CA, Dermott Fribert R, et al: Persistence of rapid growth hormone pulsatility after successful removal of GH-producing pituitary tumours. J Clin Endocrinol Metab 78:1403-1410, 1994
- (1994) J Clin Endocrinol Metab , vol.78 , pp. 1403-1410
- Ho, P.J.¹ Jaffe, C.A.² Dermott Fribert, R.³

5
- 0025333249
- Premature mortality due to cardiovascular disease in hypopituitarism
- Rosen T, Bengtsson B: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288, 1990
- (1990) Lancet , vol.336 , pp. 285-288
- Rosen, T.¹ Bengtsson, B.²

6
- 0021296574
- Drugs five years later: Bromocriptine
- Vance ML, Evans WS, Thorner MO: Drugs five years later: bromocriptine. Ann Intern Med 100:78-91, 1984
- (1984) Ann Intern Med , vol.100 , pp. 78-91
- Vance, M.L.¹ Evans, W.S.² Thorner, M.O.³

7
- 0022354853
- Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995
- Lamberts SWJ, Uitterlinden P, Verschoor L, et al: Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med 313:1576-1580, 1985
- (1985) N Engl J Med , vol.313 , pp. 1576-1580
- Lamberts, S.W.J.¹ Uitterlinden, P.² Verschoor, L.³

8
- 0025783499
- Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide
- Vance ML, Harris AG: Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Arch Intern Med 151:1573-1578, 1991
- (1991) Arch Intern Med , vol.151 , pp. 1573-1578
- Vance, M.L.¹ Harris, A.G.²

9
- 0025164701
- Long-term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients
- Sassolas G, Harris AG, James-Deider A, et al: Long-term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. J Clin Endocrinol Metab 71:391-397, 1990
- (1990) J Clin Endocrinol Metab , vol.71 , pp. 391-397
- Sassolas, G.¹ Harris, A.G.² James-Deider, A.³

10
- 0026756171
- Gallstones during octreotide therapy
- Dowling RH, Hussaini GM, Besser GM, et al: Gallstones during octreotide therapy. Metabolism 141:22-33, 1992
- (1992) Metabolism , vol.141 , pp. 22-33
- Dowling, R.H.¹ Hussaini, G.M.² Besser, G.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.